These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34465341)

  • 1. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
    Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
    BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
    Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
    Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
    Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
    J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNV Detection from Exome Sequencing Data in Routine Diagnostics of Rare Genetic Disorders: Opportunities and Limitations.
    Royer-Bertrand B; Cisarova K; Niel-Butschi F; Mittaz-Crettol L; Fodstad H; Superti-Furga A
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer.
    Agaoglu NB; Unal B; Akgun Dogan O; Zolfagharian P; Sharifli P; Karakurt A; Can Senay B; Kizilboga T; Yildiz J; Dinler Doganay G; Doganay L
    Expert Rev Mol Diagn; 2022 Feb; 22(2):239-246. PubMed ID: 35240897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of CNVs in NGS Data Using VS-CNV.
    Fortier N; Rudy G; Scherer A
    Methods Mol Biol; 2018; 1833():115-127. PubMed ID: 30039368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
    Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
    Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of next-generation sequencing to detect
    Iacocca MA; Wang J; Dron JS; Robinson JF; McIntyre AD; Cao H; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2202-2209. PubMed ID: 28874442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free-access copy-number variant detection tools for targeted next-generation sequencing data.
    Roca I; González-Castro L; Fernández H; Couce ML; Fernández-Marmiesse A
    Mutat Res Rev Mutat Res; 2019; 779():114-125. PubMed ID: 31097148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SILO: A Computational Method for Detecting Copy Number Gain in Clinical Specimens Analyzed on a Next-Generation Sequencing Platform.
    Miller N; Bouma M; Sabatini L; Gulukota K
    J Mol Diagn; 2021 Oct; 23(10):1241-1248. PubMed ID: 34365010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
    Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent count region-copy number variation (CCR-CNV): an expandable and robust tool for clinical diagnosis of copy number variation at the exon level using next-generation sequencing data.
    Kim MJ; Lee S; Yun H; Cho SI; Kim B; Lee JS; Chae JH; Sun C; Park SS; Seong MW
    Genet Med; 2022 Mar; 24(3):663-672. PubMed ID: 34906491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer.
    Moreno-Cabrera JM; Del Valle J; Feliubadaló L; Pineda M; González S; Campos O; Cuesta R; Brunet J; Serra E; Capellà G; Gel B; Lázaro C
    J Med Genet; 2022 Jan; 59(1):75-78. PubMed ID: 33219106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics.
    Povysil G; Tzika A; Vogt J; Haunschmid V; Messiaen L; Zschocke J; Klambauer G; Hochreiter S; Wimmer K
    Hum Mutat; 2017 Jul; 38(7):889-897. PubMed ID: 28449315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRACNAC: A
    Kechin A; Boyarskikh U; Borobova V; Khrapov E; Subbotin S; Filipenko M
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNV analysis in a diagnostic setting using target panel.
    Sorrentino E; Daja M; Cristofoli F; Paolacci S; Bertelli M; Marceddu G
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):7-13. PubMed ID: 34890029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical analysis of germline copy number variation in DMD using a non-conjugate hierarchical Bayesian model.
    Kozareva V; Stroff C; Silver M; Freidin JF; Delaney NF
    BMC Med Genomics; 2018 Oct; 11(1):91. PubMed ID: 30342520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.